Cargando…
Mixed response and mechanisms of resistance to larotrectinib in metastatic carcinoma ex pleomorphic adenoma of the parotid harboring an NTRK2 fusion: A case report
INTRODUCTION: Standardized systemic treatment options are lacking for carcinoma ex pleomorphic adenoma, which is a rare and aggressive tumor primarily found in salivary glands. Here we report the case of a 63-year-old male with carcinoma ex pleomorphic adenoma of the left parotid and parapharyngeal...
Autores principales: | Pircher, Magdalena, Briner, Hans Rudolf, Bonomo, Marco, Horcic, Milo, Petrausch, Ulf, Helbling, Daniel, Winder, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850688/ https://www.ncbi.nlm.nih.gov/pubmed/33530256 http://dx.doi.org/10.1097/MD.0000000000024463 |
Ejemplares similares
-
Ossifying Parotid Carcinoma ex Pleomorphic Adenoma
por: Mohan, Suresh, et al.
Publicado: (2015) -
Pleomorphic adenoma of the tongue: A case report
por: Liang, Yuanzi, et al.
Publicado: (2023) -
Adenoid Cystic Carcinoma ex Pleomorphic Adenoma of the Parotid Gland
por: Ide, Fumio, et al.
Publicado: (2009) -
Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland
por: Kinoshita, Ichita, et al.
Publicado: (2021) -
Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence
por: Ricciuti, Biagio, et al.
Publicado: (2019)